CURLF Stock Analysis & Forecast (2026)

Curaleaf Holdings, Inc. Healthcare Drug Manufacturers - Specialty & Generic
$3.13
Current Price
39%
Caution
View Plans
Data refreshed: April 22, 2026

Key Financial Metrics

Market Cap
$2.45B
Revenue Growth
0.3%
Gross Margin
49.8%
Net Margin
-18.2%
Return on Equity
-22.0%
Debt/Equity
1.23

AI Analysis Summary

Curaleaf Holdings, Inc. (CURLF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry with a 39% Caution Score. Key strengths include Gross Margin (49.8%). Areas to watch: Net Margin (-18.2%), Return on Equity (-22.0%). Our AI evaluates 8 fundamental categories including revenue growth, margin quality, balance sheet strength, cash flow generation, return on capital, and valuation metrics.

Revenue Growth: Moderate Gross Margin: Good Net Margin: Negative Return on Equity: Negative Debt/Equity: High Risk

This analysis is generated by StrongBuyAnalytics AI using publicly available financial data from SEC filings, earnings reports, and market feeds. It is not personalized investment advice. See our methodology and disclaimer.

CURLF Fundamental Analysis Report
PDF Report Preview
39%
Strong Buy Score
  • 8 Fundamental Categories Analyzed
  • Revenue & Growth Trends
  • Margin & Profitability Analysis
  • Balance Sheet Strength
  • Cash Flow Quality
  • Valuation Assessment
  • AI-Powered Investment Insights
Get Your Free CURLF Report

How It Works: AI Stock Analysis in 60 Seconds

See how our AI analyzes CURLF fundamentals to generate buy/sell signals and Strong Buy Scores.

Why CURLF Has a 39% Score

Our AI evaluates Curaleaf Holdings, Inc.'s fundamentals across multiple dimensions. Here is what is driving the current Caution rating:

Recent Catalysts for CURLF

Key developments and data points that may impact Curaleaf Holdings, Inc.'s trajectory:

Wall Street consensus target is $4.50 (+43.8% from current price), based on 2 analyst estimates.
Analyst consensus recommendation: None.

CURLF vs. Peers

How Curaleaf Holdings, Inc. stacks up against comparable Healthcare companies on key metrics:

Ticker Price Market Cap P/E Rev Growth Net Margin ROE
CURLF $3.13 $2.45B 0.3% -18.2% -22.0%
JNJ $226.16 $545.02B 20.5x 9.9% 21.8%
UNH $346.01 $314.06B 26.2x 12.3% 2.7% 12.5%
PFE $27.31 $155.35B 20.1x -1.2% 12.4% 8.9%
MRK $112.56 $278.29B 15.5x 5.0% 28.1% 36.9%

Main Risks for CURLF Investors

Every investment carries risk. Here are the specific risk factors our analysis identified for Curaleaf Holdings, Inc.:

Net Margin (-18.2%)
Return on Equity (-22.0%)
Debt/Equity (1.23)
High beta of 1.43 means the stock is 43% more volatile than the market — expect larger drawdowns in corrections.
High leverage amplifies downside risk if revenue softens or interest rates rise.

Generate the full PDF report for a detailed risk-reward framework and bear-case scenarios.

CURLF Balance Sheet & Cash Flow

A snapshot of Curaleaf Holdings, Inc.'s financial health based on the most recent filings:

Total Cash
$101.57M
Total Debt
$1.04B
Current Ratio
1.52
FCF Yield
3.6%
EBITDA
$222.06M
Operating Margin
3.2%

Data sourced from the latest SEC filings. Generate the full PDF report for detailed balance sheet and cash flow commentary.

CURLF Valuation Snapshot

Price / Book
3.2x
Premium
Analyst Target (Mean)
$4.50
Range: $4 – $5
52-Week Price Range — CURLF is trading at 56% of its range
$0.72 (52W Low) $5.05 (52W High)

Is CURLF a Buy Right Now?

Based on our AI-powered fundamental analysis, CURLF has a Strong Buy Score of 39%, earning a "Caution" rating. This score synthesizes 8 key financial metrics to provide an objective investment signal.

Caution Signal

Curaleaf Holdings, Inc. currently shows fundamental weakness that warrants careful analysis. Key concerns: Net Margin (-18.2%), Return on Equity (-22.0%). Consider waiting for improved metrics before building a position.

CURLF AI Buy & Sell Signals Explained

Our AI analyzes Curaleaf Holdings, Inc.'s financial statements to generate buy/sell signals based on quantitative metrics, not market sentiment or news headlines. Here's what drives the 39% score:

  • Revenue Growth: 0.3% year-over-year (positive)
  • Gross Margin: 49.8% (strong pricing power)
  • Net Margin: -18.2% (unprofitable)
  • Return on Equity: -22.0% (negative returns)

Generate the full PDF report for complete category-by-category scoring and AI-powered investment recommendations.

Key Support / Demand Zones

Technical traders can view real-time demand and supply zones for CURLF on our Demand Zones page. These zones identify key price levels where institutional buying or selling has historically occurred.

With CURLF currently trading at $3.13, our system monitors proximity to these critical levels and can alert you when the stock approaches support or resistance zones.

Subscribe to demand zone alerts to receive real-time notifications when CURLF reaches key technical levels.

Earnings & Revenue Outlook

Curaleaf Holdings, Inc. operates in the Healthcare sector, specifically in Drug Manufacturers - Specialty & Generic. Understanding earnings trends is crucial for forecasting CURLF's trajectory.

Current revenue growth of 0.3% slightly beats the average company.

Visit our Earnings Calendar to track upcoming CURLF earnings dates and historical beat/miss patterns. Sign up for earnings alerts to get notified before announcements.

CURLF Stock Forecast (Next 3–12 Months)

Our AI projects CURLF's trajectory based on current fundamentals and historical patterns. With a 39% Strong Buy Score, here's what the data suggests:

Cautious Outlook: Curaleaf Holdings, Inc.'s fundamentals suggest potential headwinds. Key issues: Net Margin (-18.2%). Consider waiting for improved metrics or a more attractive entry point before building a position.

For a complete 12-month price forecast with specific bull/bear scenarios, generate the full PDF report.

Valuation Metrics (P/E, Growth, Margins)

Understanding valuation is critical for determining if CURLF is fairly priced. Here's the current snapshot:

  • Market Capitalization: $2.45B
  • Debt/Equity: 1.23 (higher leverage)

Our AI weighs these metrics against growth rates and margin quality to determine if CURLF offers compelling risk-adjusted returns at current prices.

Bull Case for CURLF

Here's why investors are bullish on Curaleaf Holdings, Inc.:

  • Gross Margin (49.8%)

While these positives exist, investors should weigh them against the risks outlined in the bear case below.

Bear Case & Risks for CURLF

Every investment carries risk. Here are potential concerns for CURLF investors:

  • Net Margin (-18.2%)
  • Return on Equity (-22.0%)
  • Debt/Equity (1.23)

The full PDF report includes a detailed bear case analysis with specific risk ratings for each category.

Summary / 12-Month Outlook

CURLF Summary: Curaleaf Holdings, Inc. earns a 39% Caution Score based on AI analysis of fundamental data. Trading at $3.13 with a $2.45B market cap, the stock may face headwinds that warrant a cautious approach.

Bull Case: Gross Margin (49.8%)

Watch: Net Margin (-18.2%), Return on Equity (-22.0%)

For the complete analysis with specific price considerations, growth projections, and AI-powered buy/hold/sell recommendations, generate your free CURLF PDF report.

Learn More About Stock Analysis

Deepen your understanding of the concepts used in this CURLF analysis:

Fundamental Analysis Guide

Learn how to evaluate stocks using financial statements and key metrics.

Understanding P/E Ratio

What P/E ratio tells you about a stock's valuation and growth expectations.

Return on Equity (ROE)

Why ROE matters for stock selection and how to interpret it.

Stock Valuation Methods

Compare DCF, P/E, and other approaches to value stocks like CURLF.

What Are Demand Zones?

Find key support and resistance levels for CURLF and other stocks.

How to Read Earnings Reports

Understand earnings per share, revenue surprises, and guidance.

Related Tools for CURLF

Demand Zone Analyzer CURLF Live Chart CURLF SEC Filing News Earnings Calendar Institutional Ownership Sector Scanner Average Down Calculator

CURLF SEC Filing News

Latest SEC filings for CURLF explained in plain English — insider buys/sells (Form 4), proposed sales (Form 144), material events (8-K), and quarterly & annual reports.

Loading recent SEC filings…
View all CURLF SEC Filing News →

Frequently Asked Questions about CURLF

Is CURLF a good buy right now?
CURLF currently has a Strong Buy Score of 39% (Caution). CURLF currently shows caution signals. Review the full analysis before investing. Generate a free PDF report for specific buy/hold/sell recommendations.
What is the CURLF stock forecast for 2026?
Our AI forecasts CURLF based on current fundamentals: revenue growth of 0.3%, net margin of -18.2%. The 39% Strong Buy Score reflects our outlook combining growth trajectory, margin quality, and valuation. See the full 12-month projection in your PDF report.
What are key support and resistance levels for CURLF?
View real-time CURLF demand zones (support) and supply zones (resistance) on our Demand Zones page. With CURLF currently at $3.13, you can see how close the stock is to key technical levels. Subscribe to get alerts when CURLF approaches these zones.
How do CURLF fundamentals compare to peers?
Curaleaf Holdings, Inc. operates in the Healthcare sector. Key metrics for peer comparison: Gross margin 49.8%, ROE -22.0%, Debt/Equity 1.23. The 39% Strong Buy Score factors in how these metrics stack up against industry averages. Data is refreshed daily.
Is the CURLF analysis PDF report free?
Yes! Your first CURLF fundamental analysis report is completely free with no credit card required. The PDF includes the full Strong Buy Score breakdown, all 8 fundamental categories analyzed, AI-powered insights, and specific investment recommendations. Additional reports are available through our subscription plans starting at $24/month.
What is Curaleaf Holdings, Inc.'s market cap and P/E ratio?
Curaleaf Holdings, Inc. (CURLF) has a market cap of $2.45B. These valuation metrics are key factors in our Strong Buy Score calculation. See all metrics in the PDF report for comprehensive valuation analysis.

This CURLF analysis is for educational and informational purposes only and does not constitute financial advice. All data is sourced from public filings and market feeds. Past performance does not guarantee future results. Read our full disclaimer.